Key Topics in Gaucher Disease Addressed at a Complimentary CME Satellite Symposium During the 2015 Annual Clinical Genetics Meeting

BALTIMORE, MD—March 12, 2015—Healthcare professionals who manage patients with Gaucher disease (GD) are invited to join a panel of nationally renowned experts at a free continuing medical education (CME) satellite symposium dinner during the 2015 Annual Clinical Genetics Meeting, hosted by the American College of Medical Genetics and Genomics (ACMG). During The Evolving Therapeutic Landscape in Gaucher Disease, expert faculty will review key topics in GD, including the pathogenesis, genetic factors, and clinical manifestations associated with this disorder; the benefits and limitations of available medications; and emerging treatment strategies.

New data regarding the genetics, biochemistry, and pathophysiology of GD have provided an opportunity to expand current therapeutic approaches. As the therapeutic landscape for GD evolves, clinicians must be able to evaluate clinical symptoms and initiate or modify treatment as necessary. To help address these educational needs, our expert panel will discuss topics such as individualized treatment strategies and current and emerging therapies for GD.

“During this session, we will examine recent evidence on available treatments and review patient- and symptom-based factors to consider when making treatment decisions,” said Pramod K. Mistry, MD, PhD, FRCP, professor of medicine, pediatrics, and cellular & molecular physiology at the Yale University School of Medicine in New Haven, CT. “We will also present methods for developing treatment plans, incorporating contemporary data into clinical practice, assessing changes in GD symptoms, and determining whether treatment modifications are warranted.”

The CME satellite symposium is not part of the ACMG official scientific program. Sponsored by Med-IQ, this event will be held during the 2015 ACMG Annual Clinical Genetics Meeting at the Salt Palace Convention Center in Salt Lake City, UT, on Tuesday, March 24, 2015, from 5:30 to 7:00 PM. Dinner will be served.

For more information, interested participants can call (toll-free) 866 858 7434, e-mail info@med-iq.com, or visit www.Med-IQ.com/a840. To register and learn more about the 2015 ACMG Annual Clinical Genetics Meeting, please visit https://acmg.expoplanner.com.

This activity is approved for AMA PRA Category 1 Credit^™.

The Symposium is not part of the official ACMG Annual Clinical Genetics Meeting program, and ACMG does not approve or endorse any commercial products or services discussed during the Symposium or offered for sale by the corporate supporter of the Symposium. ACMG has reviewed and approved this symposium as appropriate for presentation as an independent educational activity held in conjunction with the ACMG Annual Clinical Genetics Meeting. ACMG has applied for Category 1 CEU approval for counselors and nurses through NSGC. Counselors and nurses may report attendance through the ACMG CE Self Reporting System. This symposium is not approved for P.A.C.E.^® credit by ACMG. CME and P.A.C.E.^® CEU credit will be available only if the supporting company has received ACCME and P.A.C.E.^® accreditations.

This activity is supported by an educational grant from Genzyme, a Sanofi company.

About Med-IQ

Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.

As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management (CRM) to improve team performance and patient outcomes. These initiatives have achieved improvement in healthcare professional performance, quality of care, and patient outcomes. Med-IQ's work in this space has been published 30 times in peer-reviewed journals, and the company has been recognized by the Alliance for Continuing Education in the Health Professions for excellence in CEhp research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership and contributions to the CEhp profession (Leadership Award 2015, 2013; Distinguished Fellow Award 2015; President’s Award 2015, 2012; Rising Star Award 2015). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.

For more information, contact:

Amy Caswell
Senior Audience Development Manager
Med-IQ
866 858 7434
info@med-iq.com


Med-IQ.
Inspiring Medical Education.